{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:46:08Z","timestamp":1792424768262,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.cgh.2019.06.029","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T10:07:20Z","timestamp":1561457240000},"page":"449-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis"],"prefix":"10.1016","volume":"18","author":[{"given":"Danny Ka-Ho","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serene Ching Yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loey Lung-Yi","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvis Wai-Pan","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina Cheuk-Lam","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan-To","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Kay","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Lung","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Fung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2019.06.029_bib2","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-induced hepatocellular carcinoma","volume":"64","author":"Levrero","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.029_bib3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/hep.24551","article-title":"Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma","volume":"54","author":"Wong","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.06.029_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cmi.2015.10.036","article-title":"Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection","volume":"22","author":"Wong","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cgh.2019.06.029_bib5","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/cncr.21702","article-title":"Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients","volume":"106","author":"Squadrito","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2019.06.029_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2893.2005.00586.x","article-title":"HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma","volume":"12","author":"Momosaki","year":"2005","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cgh.2019.06.029_bib7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","article-title":"Statements from the Taormina expert meeting on occult hepatitis B virus infection","volume":"49","author":"Raimondo","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.029_bib8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.029_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2016.08.022","article-title":"Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B","volume":"66","author":"Lai","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.029_bib10","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1053\/j.gastro.2004.03.018","article-title":"Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy","volume":"126","author":"Werle-Lapostolle","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.06.029_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.hbpd.2018.11.003","article-title":"Exonuclease I and III improve the detection efficacy of hepatitis B virus covalently closed circular DNA","volume":"18","author":"Jiang","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.cgh.2019.06.029_bib12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/jmv.1066","article-title":"State of HBV DNA in HBsAg-negative, anti-HCV-positive hepatocellular carcinoma: existence of HBV DNA possibly as nonintegrated form with analysis by Alu-HBV DNA PCR and conventional HBV PCR","volume":"64","author":"Kawai","year":"2001","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.cgh.2019.06.029_bib13","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/liv.12807","article-title":"Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma","volume":"35","author":"Saitta","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2019.06.029_bib14","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cgh.2017.02.006","article-title":"Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis","volume":"15","author":"Tansel","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.06.029_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cld.2016.02.012","article-title":"Alcoholic liver disease: high risk or low risk for developing hepatocellular carcinoma?","volume":"20","author":"Joshi","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2019.06.029_bib16","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"White","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.06.029_bib17","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/gut.2004.054452","article-title":"Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas","volume":"54","author":"Murakami","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2019.06.029_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma","volume":"44","author":"Sung","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.cgh.2019.06.029_bib19","doi-asserted-by":"crossref","first-page":"12992","DOI":"10.1038\/ncomms12992","article-title":"Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma","volume":"7","author":"Zhao","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.cgh.2019.06.029_bib20","first-page":"3225","article-title":"Molecular characterization of HBV DNA integration in patients with hepatitis and hepatocellular carcinoma","volume":"9","author":"Yang","year":"2018","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.cgh.2019.06.029_bib21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/carcin\/bgs406","article-title":"Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations","volume":"34","author":"Toh","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cgh.2019.06.029_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jhep.2018.03.021","article-title":"Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: a new tool to detect occult infection","volume":"69","author":"Caviglia","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.029_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2018.10.003","article-title":"Over-gap PCR amplification to identify presence of replication-competent HBV DNA from integrated HBV DNA: an updated occult HBV infection definition","volume":"70","author":"Liu","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.029_bib24","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2016.02.005","article-title":"Novel pre-mRNA splicing of intronically integrated HBV generates oncogenic chimera in hepatocellular carcinoma","volume":"64","author":"Chiu","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.029_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hep.26071","article-title":"MicroRNA-10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4-mediated epithelial-mesenchymal transition and adhesion in hepatoma cells","volume":"57","author":"Yan","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.06.029_bib26","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1158\/0008-5472.CAN-10-0749","article-title":"Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma","volume":"70","author":"Lee","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.cgh.2019.06.029_bib27","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.18632\/oncotarget.6978","article-title":"CTNNA3 is a tumor suppressor in hepatocellular carcinomas and is inhibited by miR-425","volume":"7","author":"He","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cgh.2019.06.029_bib28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1159\/000491811","article-title":"LncRNA NEAT1 promotes deterioration of hepatocellular carcinoma based on in\u00a0vitro experiments, data mining, and RT-qPCR analysis","volume":"48","author":"Ling","year":"2018","journal-title":"Cell Physiol Biochem"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356519306676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356519306676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:28:52Z","timestamp":1761542932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356519306676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1542356519306676"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2019.06.029","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2019.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}